Differential effects of 19-nor-1,25-(OH)2D2 and 1alpha-hydroxyvitamin D2 on calcium and phosphorus in normal and uremic rats
Open Access
- 1 October 2002
- journal article
- Published by Elsevier in Kidney International
- Vol. 62 (4) , 1277-1284
- https://doi.org/10.1046/j.1523-1755.2002.00573.x
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Osteodystrophy in the millenniumKidney International, 1999
- New Therapies Raise New Issues for Lowering Parathyroid Hormone Levels in Uremic PatientsSeminars in Dialysis, 1999
- Effective suppression of parathyroid hormone by 1α-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidismKidney International, 1997
- Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriolKidney International, 1994
- Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patientsKidney International, 1992
- Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potentialEndocrine Reviews, 1992
- Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal FailureNew England Journal of Medicine, 1989
- Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium.Journal of Clinical Investigation, 1989
- Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing DialysisNew England Journal of Medicine, 1986
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984